|
| [October 25, 2012] |
 |
Safeguard Scientifics Announces Third Quarter 2012 Financial Results
WAYNE, Pa. --(Business Wire)--
Safeguard
Scientifics, Inc. (NYSE:SFE), a holding company that builds value in
growth-stage life sciences and technology companies, today announced
that its consolidated net loss for the three months ended September 30,
2012 was $8.8 million, or $0.42 per share, compared with net income of
$22.3 million, or $1.07 per share, for the same period in 2011. For the
nine months ended September 30, 2012, the consolidated net loss was
$28.6 million, or $1.36 per share, versus net income of $135.1 million,
or $6.52 per share, for the same period in 2011.
As a result of the continued momentum at Safeguard's partner
companies, 2012 aggregate partner company revenue guidance was
increased to a range of $185 million to $190 million. This represents an
increase of 33% to 37% as compared to $139.2 million in 2011, and an
approximate increase of 15% as compared to initial 2012 revenue guidance
of $160 million to $165 million. Results for Safeguard partner companies
are reported on a one-quarter lag basis.
"Progress took many forms at Safeguard during the third quarter," said Peter
J. Boni, President and CEO of Safeguard. "Our partner companies
continue to grow, mature and achieve financial and strategic milestones.
Combined with Safeguard's value-add support at the holding company
level, our partner companies are well positioned and we remain
encouraged by our prospects to realize value in the target range
consistent with our recent results. In the meantime, the Safeguard team
remains nimble and opportunistic. We are focused on enhancing the
Company's financial strength and flexibility, as well as improving
shareholder value."
"In the aggregate, we have deployed $188.3 million of capital into our
16 current partner companies at September 30, 2012," said Stephen
T. Zarrilli, Senior Vice President and CFO at Safeguard. "Our net
cash, cash equivalents and marketable securities at September 30, 2012
totaled $183.1 million after subtracting the total carrying value of
debt outstanding of $46.2 million. Cash used in operating activities was
$3.0 million for the three months ended September 30, 2012, compared to
$3.2 million for the comparable period in 2011. We project aggregate
annual 2012 use of cash to be between $65 million and $85 million, which
is below our original projected range of $100 million to $150 million.
Cash used in operating activities for 2012 is projected to be within a
range of $17.0 million to $17.5 million."
LIFE SCIENCES PARTNER COMPANIES HIGHLIGHTS
Alverix,
Inc. (San Jose, CA - Initial Revenue Stage) produces
next-generation instrument and connectivity platforms for diagnostic
Point-of-Care (POC) testing. Alverix's systems enable laboratory class
performance in a mobile, inexpensive format, extending testing beyond
high volume sites to physician office labs, retail clinics, emerging
markets and the home, where immediate results are critical to patient
care. Alverix and Becton, Dickinson (BD) have co-developed and BD is
commercializing a proprietary point-of-care system that improves near
patient infectious-disease diagnoses. During the third quarter, BD
received 510(k) clearance from the U.S. Food and Drug Administration
(FDA) for nasopharyngeal wash, aspirate and swab in transport media
specimens on the BD VeritorTM System for Rapid Detection Flu
A + B and respiratory syncytial virus (RSV). This expands the market
opportunity to larger volume sites such as hospitals. Alverix remains
focused on growing its point-of-care platform business through
co-development of near patient test systems with select partners and
through development of its own systems. Safeguard has deployed $8.8
million of capital in Alverix since October 2007 and has a 49% primary
ownership position.
Good
Start Genetics, Inc. (Cambridge, MA - Initial Revenue
Stage) is an innovative molecular diagnostic company that has
developed more accurate and comprehensive pre-pregnancy genetic tests.
Launched in early 2012, Good Start Genetics' CLIA- and CAP-approved
offering, GoodStart
SelectTM, represents a menu of carrier screening tests
that detect more disease-causing mutations among all society-recommended
diseases than other routine screening tests. Currently, Good Start
Genetics offers tests for 23 diseases, enabling the company to claim
that it offers testing for all disorders recommended for screening by
the pertinent medical societies. Good Start Genetics' next-generation
(NGS) DNA sequencing technology combined with other best-in-class
technologies, results in higher detection rates regardless of ethnicity.
Good Start Genetics continues to target the fast growing, $1 billion
genetic testing segment. Safeguard has deployed $10.5 million of capital
in Good Start Genetics since September 2010 and has a 29% primary
ownership position.
Medivo,
Inc. (New York, NY - Initial Revenue Stage) is a
health monitoring company dedicated to helping save and improve lives
through faster and easier access to quality healthcare. Medivo collects
and organizes clinical data from labs, and symptom data from apps and
devices, and delivers easy-to-interpret reports to physicians that help
them provide better care. Medivo enables patients to better manage their
health and have more meaningful interactions with their doctors through
access to testing and mobile symptom monitoring tools,
easy-to-understand explanations of lab results, and relevant education
information. During the third quarter, Medivo appointed David Stack to
its board of directors. Mr. Stack has more than 30 years of experience
in life sciences and serves as President, CEO and Director at Pacira
Pharmaceuticals, Inc., a specialty pharmaceutical company focused on
clinical and commercial development of new products in the acute care
market. Safeguard deployed approximately $6.3 million in Medivo in
November 2011 and has a 30% primary ownership position.
NovaSom,
Inc. (Baltimore, MD - Expansion Stage) is the
market leader in Obstructive Sleep Apnea (OSA) home testing, with the
AccuSom® Home Sleep Test, the first and only FDA-cleared
wireless HST. The NovaSom home sleep testing technology and MediTrack®
portal have been shown to provide in-home, clinically equivalent
diagnosis of OSA at a significantly reduced cost as compared to
in-facility testing for uncomplicated, adult OSA. NovaSom's home sleep
tests are currently covered for more than 165 million U.S. lives,
through partnerships with major health insurers. During the third
quarter, NovaSom announced its first AccuSom Deliver partnership with
SSM Center for Sleep Disorders, a service of SSM Health Care - St.
Louis, making convenient, efficient Out-of-Center Sleep Testing (OCST)
available to patients at seven locations throughout the St. Louis, MO
area. In addition, NovaSom appointed Ron Loeppke, MD to its board of
directors. Dr. Loeppke has over 30 years of clinical and executive
experience in preventive medicine and managing health issues in the
workplace. Currently, Dr. Loeppke is Vice Chairman of U.S. Preventive
Medicine, a company focused on preventive healthcare to improve health
and reduce costs. Safeguard deployed $20.0 million in NovaSom in June
2011 and has a 30% primary ownership position.
NuPathe
Inc. (NASDAQ:PATH) (Conshohocken, PA - Development
Stage) is a specialty pharmaceutical company focused on the
development and commercialization of branded therapeutics for diseases
of the central nervous system. During the third quarter, NuPathe
announced the appointment of Armando Anido as chief executive officer of
the company. Mr. Anido brings more than 30 years of executive,
operational and commercial leadership experience in the
biopharmaceutical industry. Subsequent to the quarter, on October 23,
2012, NuPathe
completed a $28 million private placement of securities with new and
existing investors, including $5 million from Safeguard. In conjunction
with the private placement, NuPathe undertook cost containment measures
in order to focus its expenditures on the company's primary goal of
obtaining approval for its migraine patch, ZecuityTM.
If approved, Zecuity will be the first and only transdermal patch for
the treatment of migraine and is well-positioned to address
migraine-related nausea and vomiting, which are significant drivers of
disease burden. The FDA has assigned Zecuity a Prescription Drug User
Fee Act (PDUFA) date of January 17, 2013. Safeguard has deployed $23.3
million of capital in NuPathe since September 2006 and owns 18% of its
outstanding common shares.
PixelOptics,
Inc. (Roanoke, VA - Initial Revenue Stage) is a
medical technology company that developed and has begun to commercialize emPower!,
the world's first and only electronically focusing prescription eyewear.
emPower! uses dynamic technology to change focus automatically and
silently without moving parts, reducing or eliminating perceived
distortion and other limitations associated with multifocal lenses. The
company expects to roll out its Gen2 eyewear in early 2013. Safeguard
has deployed $31.7 million in PixelOptics since April 2011 and has a 25%
primary ownership position.
Putney,
Inc. (Portland, ME - Expansion Stage) is a rapidly
growing specialty pharmaceutical company developing high-quality,
cost-effective generic medicines for pets. Putney's mission is to
partner with veterinary practices to provide high quality medicines that
meet pet medical needs and offer cost-effective alternatives for pet
owners. While Americans fill 78% of their own prescriptions with
generics, only 6% of the drugs approved by the FDA for dogs and cats
have a generic equivalent, according to Putney's analysis of FDA Center
for Veterinary Medicine approvals. The total global market for companion
animal pharmaceuticals is estimated to be $5.7 billion. Safeguard
deployed $10.0 million of capital in Putney in September 2011 and has a
28% primary ownership position.
TECHNOLOGY PARTNER COMPANIES HIGHLIGHTS
AdvantEdge
Healthcare Solutions, Inc. (Warren, NJ - High Traction
Stage) is a technology-enabled provider of revenue cycle
management services, informatics and expertise, enabling healthcare
providers to maximize financial performance and eliminate compliance
risks. AdvantEdge continues to gain meaningful scale through organic
growth and strategic acquisitions, having completed seven acquisitions
since 2007. AdvantEdge is recognized as one of the top 10 medical
billing, coding and practice management companies in the U.S.; has more
than 675 employees in eight regional offices in the U.S. and one office
in Bangalore, India; and collects over $1 billion annually for its
physician clients using its own proven technology. During the third
quarter, AdvantEdge ranked on the Inc.
5000 for the fourth consecutive year, demonstrating 460 percent
revenue growth between 2008 and 2011, while also adding 350 jobs during
that same three-year period. Just recently, AdvantEdge
released its new InfoEdgeBISM platform, which gives
medical practices and hospitals more in-depth insight into their medical
billing and coding information. Safeguard has deployed $15.3 million of
capital in AHS since November 2006 and has a 40% primary ownership
position.
Beyond.com,
Inc. (King of Prussia, PA - High Traction Stage) is
The Career Network focused on helping people grow and succeed
professionally. A major player in a $12 billion online job recruitment
market, Beyond.com represents the largest network of niche career
communities, helping employers and job seekers to pinpoint the most
relevant opportunities based on location, industry and expertise.
Currently, Beyond.com is averaging one million new members a month.
During the third quarter, Beyond.com ranked on the Inc.
5000, demonstrating 65 percent revenue growth between 2008 and 2011,
while also adding 30 jobs during that same three-year period. In
addition, Beyond.com
released a study, in conjunction with Millennial Branding, on how
different generations search for jobs. The study surveyed 5,268 job
seekers and was featured in Tier 1 media outlets such as U.S.
News & World Report, PC
World, Forbes,
CIO.com
and The
Huffington Post. Safeguard has deployed $13.5 million of capital in
Beyond.com since March 2007 and has a 38% primary ownership position.
Bridgevine,
Inc. (Vero Beach, FL - High Traction Stage) is a
leading performance-based digital marketing company that delivers
superior online customer acquisition by bringing together in-market
audiences with relevant partner brands. Bridgevine's proprietary SaaS
platform powers consumer interactions with major brands, as well as
integrates with online and legacy applications for Fortune 500 clients.
Over the course of Bridgevine's partnership, these solutions have
delivered more than $2.5 billion in revenue to enterprise customers such
as Comcast, AT&T, Time Warner Cable, CenturyLink, Constellation Energy,
and DIRECTV. During the third quarter, Bridgevine
ranked on the Inc. 500|5000 for the sixth consecutive year, having
achieved 80 percent revenue growth between 2008 and 2011, while also
adding 55 jobs during that same three-year period. In addition,
Bridgevine named Todd
Cullen as Senior Vice President of Customer Insights & Analytics,
which underscores the central role that big
data, insights and analytics will play in Bridgevine's next phase of
expansion. Safeguard has deployed $10.0 million of capital in Bridgevine
since August 2007 and has a 22% primary ownership position.
DriveFactor
(Richmond, VA - Initial Revenue Stage) provides insurance
companies with a turn-key software platform that enables usage based
insurance (UBI) programs. DriveFactor has created an elegant UBI
platform that is statistically more predictive and financially more
attractive for insurance companies to implement, as well as a
privacy-sensitive, financially equitable offering for consumers.
DriveFactor is currently available in the United States, Canada and
Europe. During the third quarter, DriveFactor
launched its telematics Platform 2.0, which offers real-time access
to driving data and the ability to set different data gathering
parameters for individual devices. Platform 2.0 thus makes it easier for
insurance companies to identify responsible drivers, communicate with
their customers, and implement successful usage-based insurance
programs. Safeguard deployed $1.7 million in DriveFactor in December
2011 and has a 24% primary ownership position.
Hoopla
Software, Inc. (West Chester, PA - Initial Revenue Stage) has
developed a complete performance optimization system designed to steer
the actions and behaviors of employees. Hoopla's platform leverages
enterprise data, advanced game mechanics and sophisticated communication
tools to cultivate a high performance culture and drive results.
According to a recent report
published by Deloitte about "The Engagement Economy", 'the use of
items like leaderboards, badges, missions and levels is part of a trend
called gamification that can be seen in a growing variety of industries
and applications. It's a trend that analysts claim will be in 25 percent
of redesigned business processes by 2015, will grow to more than a $2.8
billion business by 2016, and will have 70 percent of Global 2000
businesses managing at least one "gamified" application or system by
2014.' During the third quarter, Hoopla continued to capitalize on this
trend, adding more customers to its platform, and highlighting a few
through video testimonials on its blog, including Informatica,
New
Relic, ON24,
and Zillow.
Safeguard deployed $1.3 million in Hoopla in December 2011 and has a 25%
primary ownership position.
Lumesis,
Inc. (Stamford, CT - Initial Revenue Stage) is a
software-as-a-service (SaaS), cloud-based financial technology company
dedicated to delivering software solutions and comprehensive, timely
data to the fixed income marketplace. Through sophisticated analytical
tools, real-time alerts, proprietary visualization technology and
content-rich reporting, Lumesis' DIVER solutions allow professionals
across the municipal market to easily identify portfolio risks and
opportunities, improve customer satisfaction, ensure compliance and
enable growth. During the third quarter, Lumesis named Robin Wiessmann
to its board of directors. Ms. Wiessmann brings more than 30 years of
experience as an investment banker, asset manager, entrepreneur, and
government leader. Robin has served as State Treasurer of Pennsylvania,
as a municipal investment banker with Goldman Sachs, and as founding
principal and president of investment banking firm Artemis Capital
Group. Currently, Robin is Chairman of the Vantagepoint Funds Mutual
Fund, a mutual fund company with $13 billion under management, and a
member of the Municipal Securities Rulemaking Board (MSRB). In addition,
Lumesis named Michael Vossler as Managing Director, Business
Development. Mr. Vossler has spent more than 20 years serving in various
roles within the software solutions business for capital markets
trading, operations, and enterprise risk. Most recently, he was Senior
Vice President at SunGard, overseeing sales and distribution for three
divisions, including Adaptiv, Front Arena, and Sierra. Safeguard
deployed $2.2 million in Lumesis in February 2012 and has a 32% primary
ownership position.
MediaMath,
Inc. (New York, NY - High Traction Stage) is a
leader in the demand side platform and online advertising categories,
according to a Forrester
Research DSP Wave report. The company buys billions of highly
targeted ads per month on behalf of dozens of top-tier agencies,
including all the major agency holding companies. Major brands include
American Express, Kayak, and Prudential. Today, MediaMath serves over
1,000 clients with more than 170 employees in seven offices worldwide.
During the third quarter, MediaMath ranked on the Inc.
500, demonstrating 1,319 percent revenue growth between 2008 and
2011, while also adding 98 jobs during that same three-year period. In
addition, Facebook recently named MediaMath as one of its partners for
Facebook Ad Exchange (FBX), which makes Facebook's advertising inventory
available to real-time bidding (RTB) and retargeting. Early results from
MediaMath's campaigns show that MediaMath
clients are driving higher click-throughs, conversions and brand metrics
through FBX. Safeguard has deployed $18.5 million of capital in
MediaMath since July 2009 and has a 22% primary ownership position.
Spongecell,
Inc. (New York, NY - Expansion Stage) is a digital
advertising technology company that transforms standard online ads into
dynamic ads with rich media-like functionality. During the third
quarter, Spongecell ranked #27 on the Inc.
500, up from #76 last year, having achieved 6,316 percent revenue
growth between 2008 and 2011, while also adding 41 jobs during that same
three-year period. Spongecell builds ads in 72 hours or less, allowing
creative agencies to quickly deploy interactive display ad campaigns
that increase engagement by 25 to 50 percent over static banner ads. And
now, Spongecell brings the same interactive features and the same short
build times to pre-roll advertising, offering advertisers two formats to
choose from: the
bar format, an interactive ad affixed to a video to continuously
display a company's message, and the
drawer format, an ad that retracts when not in use to offer viewers
an unobstructed view of the video. In addition to the pre-roll offering,
the company added a new polling feature and Pinterest integration to
help advertisers further boost brand engagement. Subsequent to the
quarter, Spongecell was named to Crain's New York 2012 Best Places to
Work. Safeguard deployed $10.0 million in Spongecell in January 2012 and
has a 23% primary ownership position.
ThingWorx,
Inc. (Exton, PA - Initial Revenue Stage) provides
the first software application platform designed for today's connected
world. The ThingWorx platform combines the key functionality of Web 2.0,
search, and social collaboration, and applies it to the world of
"things," including connected products, machines, sensors, and
industrial equipment. Businesses use the ThingWorx platform to rapidly
deliver innovative applications and connected solutions across markets
ranging from manufacturing, energy, and food, to M2M remote monitoring
and service, as well as in emerging "Internet of Things" applications,
including smart cities, smart grid, agriculture, and transportation.
During the third quarter, ThingWorx secured partnerships with companies
in many of these verticals including OnFarm,
nFocal,
Dirt
Road Data, IRIS
International, and Digi
International. In addition, ThingWorx
was named to the Connected World 100, which represents the 'top
companies demonstrating significant market traction and pursuing
game-changing technologies in connectivity'. Since February 2011,
Safeguard has deployed $10.0 million in ThingWorx and has a 44% primary
ownership position.
PLATFORM EXPANSION
Safeguard's partnership with Penn
Mezzanine augments our capabilities as a growth capital provider and
generates opportunities to manage external sources of capital. This
initiative is expected to produce current interest income, as well as
future management fee income and profit participation. Led by a team of
experienced mezzanine lenders, this platform enables Safeguard to
provide flexible financing strategies to current and prospective partner
companies, as well as other potential borrowers.
In August 2011, Penn Mezzanine closed its first fund, having raised more
than $64 million in the aggregate, including Safeguard's $30 million. As
of September 30, 2012, Penn Mezzanine had outstanding an aggregate of
$24.5 million in eight companies yielding 13.9%, including cash and PIK
interest. Safeguard deployed $3.9 million in Penn Mezzanine in August
2011 and has a 36% ownership position. In addition, as of September 30,
2012, Safeguard had outstanding an aggregate of $11.4 million in
connection with Penn Mezzanine's lending activities. Interest income for
the three months ended September 30, 2012 related to Penn Mezzanine
activities was $0.3 million.
SAFEGUARD SCIENTIFICS THIRD QUARTER 2012 CONFERENCE CALL
Please call at least 15 minutes prior to the call to register.
Date: Thursday, October 25, 2012
Time: 9:00am EDT
Webcast: www.safeguard.com/results
Call-in Number: 877-317-6789 // (International) +412-317-6789
Replay Number: 877-344-7529 // (International) +412-317-0088
Replay Access Code: 1001974
Replay available through November 26, 2012 at 9:00am EST
Speakers: President and CEO Peter
J. Boni; Senior Vice President and CFO Stephen
T. Zarrilli
Format: Discussion of third quarter 2012 financial results
followed by Q&A.
For more information please contact IR@safeguard.com.
EVENTS
FOLLOW US
Safeguard Scientifics will be tweeting live during today's conference
call. Follow Safeguard's StockTwits symbol $SFE
for up-to-date information.
About Safeguard Scientifics
Founded in 1953 and based in Wayne, PA, Safeguard Scientifics, Inc.
(NYSE: SFE) provides growth capital for entrepreneurial and innovative
life sciences and technology companies. Safeguard targets life sciences
companies in Molecular and Point-of-Care Diagnostics, Medical Devices,
Regenerative Medicine, Specialty Pharmaceuticals and selected healthcare
services, and technology companies in Internet / New Media, Financial
Services IT, Healthcare IT and selected business services with capital
requirements of up to $25 million. Safeguard participates in expansion
financings, corporate spin-outs, management buyouts, recapitalizations,
industry consolidations and early-stage financings. For more
information, please visit our website at www.safeguard.com
or our blog (blog.safeguard.com).
Forward-looking Statements
Except for the historical information and discussions contained
herein, statements contained in this release may constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Our forward-looking statements
are subject to risks and uncertainties. The risks and uncertainties that
could cause actual results to differ materially include, among others,
managing rapidly changing technologies, limited access to capital,
competition, the ability to attract and retain qualified employees, the
ability to execute our strategy, the uncertainty of the future
performance of our companies, acquisitions and dispositions of
companies, the inability to manage growth, compliance with government
regulations and legal liabilities, additional financing requirements,
the effect of economic conditions in the business sectors in which our
companies operate, and other uncertainties described in the Company's
filings with the Securities and Exchange Commission. Many of these
factors are beyond our ability to predict or control. As a result of
these and other factors, our past financial performance should not be
relied on as an indication of future performance. The Company does not
assume any obligation to update any forward-looking statements or other
information contained in this news release.
|
|
|
|
|
Safeguard Scientifics, Inc.
|
|
Condensed Consolidated Balance Sheets
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
December 31,
|
|
|
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Cash, cash equivalents and marketable securities
|
|
$
|
191,468
|
|
$
|
241,285
|
|
Restricted cash equivalents and cash held in escrow
|
|
|
11,743
|
|
|
11,570
|
|
Other current assets
|
|
|
1,834
|
|
|
1,081
|
|
Total current assets
|
|
|
205,045
|
|
|
253,936
|
|
Ownership interests in and advances to partner companies and funds
|
|
|
118,131
|
|
|
114,169
|
|
Loan participations receivable
|
|
|
8,860
|
|
|
7,587
|
|
Available-for-sale securities
|
|
|
9,648
|
|
|
5,184
|
|
Long-term marketable securities
|
|
|
37,811
|
|
|
16,287
|
|
Long-term restricted cash equivalents
|
|
|
2,376
|
|
|
7,128
|
|
Other assets
|
|
|
2,153
|
|
|
2,345
|
|
Total Assets
|
|
$
|
384,024
|
|
$
|
406,636
|
|
|
|
|
|
|
|
|
Liabilities and Equity
|
|
|
|
|
|
Total current liabilities
|
|
$
|
6,285
|
|
$
|
8,516
|
|
Other long-term liabilities
|
|
|
3,970
|
|
|
4,146
|
|
Convertible senior debentures - non-current
|
|
|
46,215
|
|
|
45,694
|
|
Total equity
|
|
|
327,554
|
|
|
348,280
|
|
Total Liabilities and Equity
|
|
$
|
384,024
|
|
$
|
406,636
|
|
|
|
|
|
|
|
|
|
|
|
Safeguard Scientifics, Inc.
|
|
Condensed Consolidated Statements of Operations
|
|
(in thousands except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
$
|
4,790
|
|
|
$
|
5,100
|
|
|
$
|
14,681
|
|
|
$
|
15,554
|
|
|
Operating loss
|
|
|
(4,790
|
)
|
|
|
(5,100
|
)
|
|
|
(14,681
|
)
|
|
|
(15,554
|
)
|
|
Other income (loss), net interest and equity income (loss)
|
|
|
(3,967
|
)
|
|
|
27,431
|
|
|
|
(13,873
|
)
|
|
|
150,690
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) before income taxes
|
|
|
(8,757
|
)
|
|
|
22,331
|
|
|
|
(28,554
|
)
|
|
|
135,136
|
|
|
Income tax benefit (expense)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Net income (loss)
|
|
$
|
(8,757
|
)
|
|
$
|
22,331
|
|
|
$
|
(28,554
|
)
|
|
$
|
135,136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.42
|
)
|
|
$
|
1.07
|
|
|
$
|
(1.36
|
)
|
|
$
|
6.52
|
|
|
Diluted
|
|
$
|
(0.42
|
)
|
|
$
|
0.98
|
|
|
$
|
(1.36
|
)
|
|
$
|
5.68
|
|
|
|
|
|
|
|
|
|
|
|
|
Average shares used in computing net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
20,999
|
|
|
|
20,790
|
|
|
|
20,935
|
|
|
|
20,737
|
|
|
Diluted
|
|
|
20,999
|
|
|
|
24,291
|
|
|
|
20,935
|
|
|
|
24,573
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Safeguard Scientifics, Inc.
|
|
Segment Results
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Loss
|
|
|
|
|
|
|
|
|
|
Life Sciences
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
Technology
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Penn Mezzanine
|
|
|
(2
|
)
|
|
|
-
|
|
|
|
(6
|
)
|
|
|
-
|
|
|
Total segment results
|
|
|
(2
|
)
|
|
|
-
|
|
|
|
(6
|
)
|
|
|
-
|
|
|
Other items (a)
|
|
|
(4,788
|
)
|
|
|
(5,100
|
)
|
|
|
(14,675
|
)
|
|
|
(15,554
|
)
|
|
|
|
$
|
(4,790
|
)
|
|
$
|
(5,100
|
)
|
|
$
|
(14,681
|
)
|
|
$
|
(15,554
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss)
|
|
|
|
|
|
|
|
|
|
Life Sciences
|
|
$
|
(5,642
|
)
|
|
$
|
(4,188
|
)
|
|
$
|
(12,094
|
)
|
|
$
|
126,238
|
|
|
Technology
|
|
|
2,339
|
|
|
|
32,896
|
|
|
|
1,566
|
|
|
|
28,149
|
|
|
Penn Mezzanine
|
|
|
423
|
|
|
|
-
|
|
|
|
340
|
|
|
|
-
|
|
|
Total segment results
|
|
|
(2,880
|
)
|
|
|
28,708
|
|
|
|
(10,188
|
)
|
|
|
154,387
|
|
|
Other items (a)
|
|
|
(5,877
|
)
|
|
|
(6,377
|
)
|
|
|
(18,366
|
)
|
|
|
(19,251
|
)
|
|
Net Income (Loss)
|
|
$
|
(8,757
|
)
|
|
$
|
22,331
|
|
|
$
|
(28,554
|
)
|
|
$
|
135,136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Other items includes corporate expenses and private equity fund
activity.
|
|
Safeguard Scientifics, Inc.
|
|
Partner Company Financial Data
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional Financial Information
|
|
|
|
|
|
|
|
|
To assist investors in understanding Safeguard and our 16 partner
companies as of September 30,
|
|
2012, we are providing additional financial information on our
partner companies, including the
|
|
aggregate cost and carrying value for all of our partner companies
and other holdings. Carrying value
|
|
of an equity method partner company represents the original
acquisition cost and any follow-on funding,
|
|
plus or minus our share of the earnings or losses of each company,
reduced by any impairment
|
|
charges. The carrying value and cost data reflect our percentage
holdings in the partner companies.
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
|
|
|
|
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Value
|
|
Cost
|
|
Safeguard Carrying Value and Cost
|
|
|
|
|
Equity method partner companies
|
$
|
109,629
|
|
$
|
169,996
|
|
Other holdings
|
|
|
|
8,502
|
|
|
38,267
|
|
|
|
|
$
|
118,131
|
|
$
|
208,263
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale securities
|
|
$
|
9,648
|
|
$
|
27,349
|

[ Back To Contact Center Solutions Homepage's Homepage ]
|